InvestorsHub Logo

Tiger Money

01/03/21 9:27 PM

#33257 RE: J-Belfort #33254

Fair enough. Thank you. I would love for them to just put it in the FDA's face since the FDA is bunch of crooks. Their science can't be refuted and the FDA would have no defense against what RLFTF could say.

Oh well, also, I guess I'm still pissed the FDA asked them to bump up the participants from whatever it was 125 to 165. i guess for once, now thinking about it, the FDA finally cared for 40 lives at least, as they wanted the study expanded. otherwise, they would have sit on it and those 40 lives might have not been saved.

TurdBlossom

01/04/21 3:11 AM

#33260 RE: J-Belfort #33254

Thank you for your factual contributions JB. I have learned a lot from your posts and I appreciate the time you spend sharing your information. I have been invested since May and I hold a high average cost because of my FOMO tuition. Another thing I learned is that no amount of positive thinking or cursing will change the timeline or SP. Everything depends on supply and demand.
I invested in RLFTF because of VIP - in the ancient war against microorganisms mammals evolved VIP, a protein so perfect that it remains unchanged and is identical in humans and mice even today. The ‘inhibit viral replication, stop the cytokine storm, protect aveolar type II cells’,
etc. is just scratching the surface of VIP applications. Thanks to COVID-19, we are all presented with an unique investment opportunity because when will we ever be able to own a product with global demand? GLOBAL. I am not talking about “I want an iphone” demand but rather “I don’t want to die” demand.
It doesn’t matter what the FDA motives are. It is inevitable the data will be released and if the FDA drags its feet acting on data from a gold standard double blind RCT study then the rest of the world and the respective regulatory agencies are free to use the study to make their own decisions. The US is big but the rest of the world is bigger. RLFTF gets 50% of sales profits in US, Canada, and Israel/ 85% Europe/ 80% rest of the world. An effective drug which is an endogenously occurring peptide in humans so it is safe AND cheap to produce? Europe, China, India... Supply and demand. Good for Covid and beyond. IMHO. GLTA

Best,
TB

SF Anony

01/04/21 9:53 AM

#33268 RE: J-Belfort #33254

When you’re the David trying to get a drug approved, and a bunch of Goliaths have influence over the regulatory agency, you have to do EVERYTHING 100% correctly. I also hold CYDY, and they came to that realization too. A lot of impatient traders were clamoring for them to unblind their Severe/Critical trial early. The company is pressing ahead to full completion. In my opinion, that’s the only way to get these small company drugs to EUA and full approval. ALL of the i’s have to be dotted and t’s have to be crossed. There’s too much at stake for Big Pharma, and they will take advantage of any opportunity to pressure the FDA to send RLFTF back to START without passing GO or collecting any money.

Demolition Man

01/04/21 10:14 AM

#33272 RE: J-Belfort #33254

Happy new year!! Relief is looking to pop big time! Hope you all big time success!!!